PHARMACYTE BIOTECH INC (PMCB:NASDAQ)

$0.762 0.0119 (1.5865%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PHARMACYTE BIOTECH INC (PMCB:NASDAQ) News Sources

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

18-08-2025

yahoo.com

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

20-08-2025

yahoo.com

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

25-11-2025

yahoo.com

BC-Most Active Stocks

04-12-2025

yahoo.com

PHARMACYTE BIOTECH INC (PMCB:NASDAQ) Sentiment Trend

0 25 50 75 100 78 46 62 85 18-08-2025 20-08-2025 25-11-2025 04-12-2025 #1 #2 #3 #4 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PHARMACYTE BIOTECH INC (PMCB:NASDAQ) FAQs

toggle

What is the current price of PHARMACYTE BIOTECH INC (PMCB:NASDAQ)?

The current price of PHARMACYTE BIOTECH INC (PMCB:NASDAQ) is $0.762.


toggle

PHARMACYTE BIOTECH INC (PMCB:NASDAQ) absolute price change since previous trading day?

The absolute price change of PHARMACYTE BIOTECH INC (PMCB:NASDAQ) since the previous trading day is $0.0119.


toggle

PHARMACYTE BIOTECH INC (PMCB:NASDAQ) percentage price change since previous trading day?

The percentage price change of PHARMACYTE BIOTECH INC (PMCB:NASDAQ) since the previous trading day is 1.5865%.


toggle

What is the most recent average sentiment score for PHARMACYTE BIOTECH INC (PMCB:NASDAQ)?

The most recent average sentiment score for PHARMACYTE BIOTECH INC (PMCB:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for PHARMACYTE BIOTECH INC (PMCB:NASDAQ)?

The most recent sentiment for PHARMACYTE BIOTECH INC (PMCB:NASDAQ) is .


SEC-8K** Filing Available For PHARMACYTE BIOTECH INC (PMCB:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.